Athlete's Foot Market

Market Overview:

The 7 major athlete's foot markets reached a value of US$ 675.3 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 860.5 Million by 2034, exhibiting a growth rate (CAGR) of 2.23% during 2024-2034.

The athlete's foot market has been comprehensively analyzed in IMARC's new report titled "Athlete's Foot Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034". Athlete's foot, which is also referred to as tinea pedis, is a fungal infection that affects the skin on the feet, particularly between the toes. The symptoms of the disorder can vary from person to person but typically include itching, burning, and stinging on the impacted area. The skin may also become scaly, dry, and flaky, and blisters or ulcers may develop in severe cases. Additionally, the infection can spread to other areas of the feet, as well as to the toenails, causing them to become thick, brittle, and discolored. In some instances, the disease may also cause a foul odor or a rash on the foot. Diagnosing the ailment usually involves a physical examination of the affected area, as well as a review of medical history and symptoms. In certain cases, a skin culture is taken to identify the specific type of fungus causing the infection. This entails taking a small sample of the affected skin and sending it to a laboratory for analysis. Various other tests, such as a skin scraping or a Wood's lamp examination, are also used to help diagnose the infection.

The increasing cases of fungal infections caused by exposure to warm and humid environments or poor foot hygiene are primarily driving the athlete's foot market. In addition to this, the rising prevalence of numerous associated risk factors, including weakened immune system, wearing tight-fitting footwear, genetic predisposition, etc., is also bolstering the market growth. Furthermore, the widespread adoption of antifungal powders, such as talcum or zeasorb, to keep the feet dry and prevent the formation of fungus is acting as another significant growth-inducing factor. Apart from this, the escalating demand for over-the-counter pain relievers, including ibuprofen or acetaminophen, for relieving pain and discomfort associated with athlete's foot is further creating a positive outlook for the market. Moreover, the inflating utilization of probiotics, since they aid in reducing fungal infections by promoting a healthy balance of microorganisms on the skin, is also augmenting the market growth. Additionally, the introduction of sterilizing shoes with antifungal sprays or UV light, which can help kill fungus and prevent reinfection, is expected to drive the athlete's foot market in the coming years.

IMARC Group's new report provides an exhaustive analysis of the athlete's foot market in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. This includes treatment practices, in-market, and pipeline drugs, share of individual therapies, market performance across the seven major markets, market performance of key companies and their drugs, etc. The report also provides the current and future patient pool across the seven major markets. According to the report the United States has the largest patient pool for athlete's foot and also represents the largest market for its treatment. Furthermore, the current treatment practice/algorithm, market drivers, challenges, opportunities, reimbursement scenario and unmet medical needs, etc. have also been provided in the report. This report is a must-read for manufacturers, investors, business strategists, researchers, consultants, and all those who have any kind of stake or are planning to foray into the athlete's foot market in any manner.

Time Period of the Study

• Base Year: 2023
• Historical Period: 2018-2023
• Market Forecast: 2024-2034

Countries Covered

• United States
• Germany
• France
• United Kingdom
• Italy
• Spain
• Japan
   

Analysis Covered Across Each Country

• Historical, current, and future epidemiology scenario
• Historical, current, and future performance of the athlete's foot market
• Historical, current, and future performance of various therapeutic categories in the market
• Sales of various drugs across the athlete's foot market
• Reimbursement scenario in the market
• In-market and pipeline drugs

Competitive Landscape:

This report also provides a detailed analysis of the current athlete's foot marketed drugs and late-stage pipeline drugs.

In-Market Drugs

• Drug overview
• Mechanism of action
• Regulatory status
• Clinical trial results
• Drug uptake and market performance
   

Late-Stage Pipeline Drugs

• Drug overview
• Mechanism of action
• Regulatory status
• Clinical trial results
• Drug uptake and market performance
   

*Kindly note that the drugs in the above table only represent a partial list of marketed/pipeline drugs, and the complete list has been provided in the report.

Key Questions Answered in this Report:

Market Insights

• How has the athlete's foot market performed so far and how will it perform in the coming years?
• What are the markets shares of various therapeutic segments in 2023 and how are they expected to perform till 2034?
• What was the country-wise size of the athlete's foot market across the seven major markets in 2023 and what will it look like in 2034?
• What is the growth rate of the athlete's foot market across the seven major markets and what will be the expected growth over the next ten years?
• What are the key unmet needs in the market?
   

Epidemiology Insights

• What is the number of prevalent cases (2018-2034) of athlete's foot across the seven major markets?
• What is the number of prevalent cases (2018-2034) of athlete's foot by age across the seven major markets?
• What is the number of prevalent cases (2018-2034) of athlete's foot by gender across the seven major markets?
• How many patients are diagnosed (2018-2034) with athlete's foot across the seven major markets?
• What is the size of the athlete's foot patient pool (2018-2023) across the seven major markets?
• What would be the forecasted patient pool (2024-2034) across the seven major markets?
• What are the key factors driving the epidemiological trend of athlete's foot?
• What will be the growth rate of patients across the seven major markets?
   

Athlete's Foot: Current Treatment Scenario, Marketed Drugs and Emerging Therapies

• What are the current marketed drugs and what are their market performance?
• What are the key pipeline drugs and how are they expected to perform in the coming years?
• How safe are the current marketed drugs and what are their efficacies?
• How safe are the late-stage pipeline drugs and what are their efficacies?
• What are the current treatment guidelines for athlete's foot drugs across the seven major markets?
• Who are the key companies in the market and what are their market shares?
• What are the key mergers and acquisitions, licensing activities, collaborations, etc. related to the athlete's foot market?
• What are the key regulatory events related to the athlete's foot market?
• What is the structure of clinical trial landscape by status related to the athlete's foot market?
• What is the structure of clinical trial landscape by phase related to the athlete's foot market?
• What is the structure of clinical trial landscape by route of administration related to the athlete's foot market?